Target intelligence / Profile preview

Vomeronasal 2 receptor 19, pseudogene (VN2R19P)

Target: VN2R19P
Molecular classification: Pseudogene, (historically related to) Receptor

Overview

Vomeronasal 2 receptor 19, pseudogene (VN2R19P) is a transcribed, unitary pseudogene located on human chromosome 19 (19q13.43)[1][7]. While the gene is homologous to vomeronasal receptors involved in chemosensory signal transduction in other species, in humans it does not code for a functional receptor protein. There is no evidence that VN2R19P has any biological activity, is involved in disease, or is a therapeutic or diagnostic target. The designation as a pseudogene means it is a remnant of an ancestral receptor gene, and as such, it is not classified as a drug target[1][3][5][7].

Mechanism of action

None

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on Vomeronasal 2 receptor 19, pseudogene (VN2R19P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vomeronasal 2 receptor 19, pseudogene (VN2R19P).

Explore the full profile